Sections

Services

Information

US United States

Pharmaceuticals

Articles (1 - 20 of 53)

Pills ok during pregnancy? We can’t know if we don’t study them. Medications image via www.shutterstock.com

Pregnant women must be studied too

Imagine being pregnant while having a chronic health condition such as diabetes, hypertension, depression or asthma, or being diagnosed with an illness while pregnant. Amazingly, your doctor may not know…
What if an experimental treatment seems to hold a terminal patient’s only hope? Pill bottle image via www.shutterstock.com

‘Right to try’ laws are compassionate, but misguided

On November 4, the state of Arizona will decide whether to join Colorado, Missouri, Louisiana and Michigan in passing so-called right to try laws. If passed, the “Arizona Terminal Patients’ Right To Try…
Central to the processes of the PBS is the idea that drugs with identical or similar clinical outcomes should have similar prices. Thinglass/Shutterstock

How the US trade deal undermined Australia’s PBS

Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…
Reduced access to generics drugs has contributed to the 80% rise in the cost of Australia’s Pharmaceutical Benefits Scheme. Diego Cervo/Shutterstock

It’s time to fix the free trade bungle on the cost of medicines

Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…
It’s not yet clear how the Coalition will weigh health issues against economic priorities. jdwfoto/Shutterstock

Coalition’s policy bodes ill for health in free trade negotiations

Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…
Drug reps form a huge part of the industry’s marketing strategy. Alexander Raths/Shutterstock

Why I don’t see drug reps – a GP’s take on Big Pharma spruiking

Here’s what I remember. It was 14 years ago, and I was a junior doctor working in psychiatry. Some colleagues planned a dinner as an end-of-term celebration and, despite reasonable incomes, they decided…
Developing the IPOs of tomorrow. UCL maps

Med City can galvanise science and business in the UK

Med City was launched to great fanfare last week by the Mayor of London, Boris Johnson. Bringing together the powerhouses of academic and clinical research at UCL, Imperial, Kings, Oxford and Cambridge…
Some drug manufacturing in India is global best practice. Other production is both shoddy and dangerous. Shutterstock

Regulator silent on safety of Indian-made generic drugs

Generic drugs are copies of brand-name drugs whose patent has expired, allowing consumers (and governments) to buy a replica drug at a fraction of the price. But a recent US investigation has found consumers…
Cancer targets young and old. National Cancer Institute

EU loophole means children with cancer are denied drugs

In spite of a major drive to develop targeted drugs to “personalise” cancer treatments, children with cancer still have to put up with drugs that have remained largely unchanged for decades. Currently…
No antibiotic resistant bacteria please - in your pork, beef, chicken, or throat. Dr Graham Beards

Charge fees for farm antibiotics to slow the spread of superbugs

The development of resistant bacteria over the past 50 years stands testament to the power of evolution. While scientists have discovered or created hundreds of antibiotics to kill bacteria, those bacteria…
It’s not all about the money but universities could drive a harder bargain. Victor1558

Universities are research power houses but fail to reap rewards

In the pharmaceutical industry there is a place known as the Valley of Death. It is the place between research and innovation where many drugs enter but fail to emerge from the other side. One reason for…
Amgen has found itself at the centre of the Australian body politic. AAP/Paul Jeffers

Amgen and Abbott: who’s that on the PM’s cycling kit?

You may have noticed our Prime Minister Tony Abbott riding around in cycling kit with the Amgen logo across his chest, back and legs. Amgen is the principal sponsor of an Australian fundraising cycling…
Prescriptions for pain relief are easy to get in the UK but not if you live in certain countries. PA/Julien Behal

Pain-relief access crisis leaves millions suffering around globe

Ten percent of the world consumes 90% of the morphine. At first glance that’s just another statistic about haves and have nots. But it’s more stark than that - particularly if you have cancer in a country…
The biggest and fastest-growing spending category in health is hospitals. Image from shutterstock.com

Tough choices: how to rein in Australia’s rising health bill

With health costs rising and costly medical innovations on the horizon, it’s crunch time for health funding. In the lead up to the May budget, The Conversation’s experts will explore the options for reining…

Top contributors

More